-
The manufacturing method of Yongan Pharmaceutical's taurine obtained a patent certificate issued by the Japanese Patent Office
Time of Update: 2021-11-13
On November 5, Yongan Pharmaceutical issued an announcement stating that the manufacturing method of taurine had recently received a patent certificate issued by the Japanese Patent Office .
-
Throat diseases hit the season with high incidence, and pharmaceutical companies are rushing to grab the 5 billion throat Chinese patent medicine market
Time of Update: 2021-11-13
For example, according to relevant data, in 2020, the sales of terminal throat Chinese patent medicines in physical pharmacies in Chinese cities will exceed 4.
In the field of throat Chinese patent medicines, representative companies include Yangzijiang Pharmaceutical, Guilin Sanjin, Golden Throat, Guilong Pharmaceutical, and Jiangzhong Pharmaceutical .
-
The world's first targeted human interleukin-5 antibody biologics approved for marketing, Xin Kelai debuts at the 4th CIIE
Time of Update: 2021-11-13
Shanghai, November 6, 2021/PRNewswire/ - Today, at the 4th China International Import Expo, Xinkelai (generic name: mepolizumab) became the world's first target approved for marketing The identity of human interleukin-5 (IL-5) antibody biologics was officially unveiled, hoping to provide new treatment options for Chinese patients and families affected by inflammatory diseases caused by eosinophilia .
-
Gale and Suzhou Corning Jerry signed a global exclusive development agreement for ASC22 (Envolimab) for the treatment of hepatitis B and other viral diseases
Time of Update: 2021-11-13
Under the terms of the agreement, Corning Jerry Suzhou song ceremony to grant the development and commercialization ASC22 outside Greater China exclusive worldwide rights, authorized indications for all viral diseases, including hepatitis B, including .
-
Supporting the submission of new drug applications this year, the key clinical trial results of innovative RNAi therapy are positive
Time of Update: 2021-11-13
The trial reached the primary endpoint, that is, nedosiran caused a statistically significant decrease in urine oxalate excretion (Uox) in patients with PH1 subtype compared with placebo .
-
CIIE strives to promote innovation and cooperation, Boehringer Ingelheim and Shanghai Zhijiang Biotech signed a CDMO cooperation agreement for the new crown bispecific antibody drug
Time of Update: 2021-11-13
Boehringer Ingelheim will provide process optimization and commissioned production services for Shanghai Zhijiang Biotech's new coronary pneumonia antibody drug SYZJ001 Biopharmaceutical contract deve
-
"Latest Breaking News" One-on-one one-on-one bringing back blood mentors "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
Shuanglu Pharmaceutical's long-acting recombinant human glucagon-like peptide-1 injection was approved for clinical use
Time of Update: 2021-11-13
By activating GLP-1 receptors, it can not only promote insulin secretion, but also reduce the secretion of glucagon (glucagon) to achieve the purpose of lowering blood sugar; it can also reduce the source of glucose by reducing appetite and delay gastric excretion.
-
"Latest Breaking News" Instructor single with one-on-one blood back skills "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
November 26!
Time of Update: 2021-11-13
At the same time, the Joint Procurement Office issued a notice on the implementation of the sixth batch of national-organized centralized drug procurement (insulin special) drug information filling work, requiring that this centralized procurement product obtain a valid domestic registration approval document before November 14, 2021 (inclusive) The quality of the listed drugs meets the standards of the relevant national departments and is produced in accordance with the requirements of the relevant departments .
-
"Latest Breaking News" Big and small single and double tutors bring money to make money "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 morphology is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
How much has the price of centralized procurement of drugs into pharmacies dropped?
Time of Update: 2021-11-13
In October 2021, the country's fifth batch of centralized procurement of drugs will be implemented, and retail pharmacies will continue to participate in the expansion of centralized procurement .
-
How does the market outlook for the pharmaceutical sector go?
Time of Update: 2021-11-13
The agency believes that in terms of investment, in addition to focusing on the first-line leading companies, it is also possible to find specialized and new small leaders in various sub-fields from the bottom up, including: the innovative drug industry chain and the upstream of life sciences, with high prosperity CXO and fast-growing upstream support companies in life sciences; innovative drugs and innovative devices; vaccines; consumption upgrades; medical services, etc.
-
The tens of billions of VEGF pharmaceutical ophthalmic market, ushered in spoilers!
Time of Update: 2021-11-13
The currently approved anti-VEGF antibody drugs are all Monospecific antibodies, among them, ranibizumab, conbercept and aflibercept, the three major antibody products, occupy a huge market segment .
-
Expanded AlphaFold application Google parent company established AI-driven drug discovery company
Time of Update: 2021-11-13
In November last year, DeepMind successfully used its deep learning model AlphaFold artificial intelligence system to accurately predict the 3D structure of proteins based on amino acid sequences .
-
A number of long-term prescription policies have been released this year, and prescription sinking will accelerate
Time of Update: 2021-11-13
For example, in March, the National Health Commission issued the "Notice on Doing a Good Job in the Management of Long-term Prescriptions for Chronic Diseases", requesting the strengthening of daily medical service management, and encouraging the formulation and improvement of long-term prescription management policies for patients with chronic diseases based on local conditions.
-
"The latest news" 200 yuan blood return 10,000 skills "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
"Latest Breaking News" Leading the most stable and powerful rebirth mentor "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
In the new pharmaceutical retail field, strong alliances have become a trend!
Time of Update: 2021-11-13
On November 4, it was reported that Sinopharm Investment and Huawei "hand in hand", and the two sides are carrying out in-depth strategic cooperation in building new pharmaceutical retail, intelligent manufacturing and digital transformation to help realize the healthy China strategy and better meet the needs of grassroots people for medical and health services .
-
Multi-party efforts to promote faster access to innovative drugs for hematological tumors
Time of Update: 2021-11-13
Professor Li Juan of the First Affiliated Hospital of Sun Yat-sen University said: “In response to the urgent treatment needs of patients with multiple myeloma, we hope that a variety of innovative drugs, including Sarclisa®, can be introduced into clinical use .
